Core PeptidesProduct page includes use or preparation wordingIn stock
Triptorelin · 2 mg × 1 vial
$54.00$27.00 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
Triptorelin research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 2 mg × 1 vial$27.00 / mg · $54.00Core Peptides · checked 5 days ago
Listings at 2 mg × 1 vial
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Core PeptidesProduct page includes use or preparation wording | 2 mg × 1 vial | $54.00 | $27.00 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for Triptorelin. Current means seen in the last 8 days.
| 2 mg × 1 vial | $54.00 | $27.00 / mg | 1 / 1 | 1 |
|---|
Research context
From our own records, with the date each was last checked.
- FDA approval
- Approved under NDAs: Trelstar (triptorelin pamoate, first approved 2000-06-15) and Triptodur (2017-06-29)Checked
- 503A / 503B compounding
- Not in any 503A category on FDA's 2026-05-14 listChecked
- Advisory committee (PCAC)
- No PCAC meeting on triptorelin found on FDA's 2022 to 2027 PCAC meeting pages (checked 2026-11-03)Checked
- Rulemaking / enforcement
- No rule on human drug compounding found (search on 2026-11-03); FDA matches concern new animal drugs, a patent-term notice and bioequivalence guidanceChecked
- WADA
- S2.2.1 Testosterone-stimulating peptides in males · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
- Identity
- Formula C64H82N18O13 · MW 1311.4 g/mol · CAS 57773-63-4Sequence pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2Source record Checked
Identity noteResearch listings are not Trelstar or Triptodur and are not FDA-approved medicines. Some sellers label it "GnRH"; GnRH itself is gonadorelin, a different molecule.
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.